Global Neuraminidase Inhibitor Market Research Report 2022
SKU ID : QYR-21594092 | Publishing Date : 01-Sep-2022 | No. of pages : 88
Detailed TOC of Global Neuraminidase Inhibitor Market Research Report 2022
1 Neuraminidase Inhibitor Market Overview1.1 Product Overview and Scope of Neuraminidase Inhibitor
1.2 Neuraminidase Inhibitor Segment by Type
1.2.1 Global Neuraminidase Inhibitor Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Laninamivir
1.3 Neuraminidase Inhibitor Segment by Application
1.3.1 Global Neuraminidase Inhibitor Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 Others
1.4 Global Neuraminidase Inhibitor Market Size Estimates and Forecasts
1.4.1 Global Neuraminidase Inhibitor Revenue 2017-2028
1.4.2 Global Neuraminidase Inhibitor Sales 2017-2028
1.4.3 Neuraminidase Inhibitor Market Size by Region: 2017 Versus 2021 Versus 2028
2 Neuraminidase Inhibitor Market Competition by Manufacturers
2.1 Global Neuraminidase Inhibitor Sales Market Share by Manufacturers (2017-2022)
2.2 Global Neuraminidase Inhibitor Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Neuraminidase Inhibitor Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Neuraminidase Inhibitor Manufacturing Sites, Area Served, Product Type
2.5 Neuraminidase Inhibitor Market Competitive Situation and Trends
2.5.1 Neuraminidase Inhibitor Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neuraminidase Inhibitor Players Market Share by Revenue
2.5.3 Global Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuraminidase Inhibitor Retrospective Market Scenario by Region
3.1 Global Neuraminidase Inhibitor Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Neuraminidase Inhibitor Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Neuraminidase Inhibitor Market Facts & Figures by Country
3.3.1 North America Neuraminidase Inhibitor Sales by Country
3.3.2 North America Neuraminidase Inhibitor Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Neuraminidase Inhibitor Market Facts & Figures by Country
3.4.1 Europe Neuraminidase Inhibitor Sales by Country
3.4.2 Europe Neuraminidase Inhibitor Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neuraminidase Inhibitor Market Facts & Figures by Region
3.5.1 Asia Pacific Neuraminidase Inhibitor Sales by Region
3.5.2 Asia Pacific Neuraminidase Inhibitor Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Neuraminidase Inhibitor Market Facts & Figures by Country
3.6.1 Latin America Neuraminidase Inhibitor Sales by Country
3.6.2 Latin America Neuraminidase Inhibitor Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neuraminidase Inhibitor Market Facts & Figures by Country
3.7.1 Middle East and Africa Neuraminidase Inhibitor Sales by Country
3.7.2 Middle East and Africa Neuraminidase Inhibitor Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Neuraminidase Inhibitor Historic Market Analysis by Type
4.1 Global Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)
4.2 Global Neuraminidase Inhibitor Revenue Market Share by Type (2017-2022)
4.3 Global Neuraminidase Inhibitor Price by Type (2017-2022)
5 Global Neuraminidase Inhibitor Historic Market Analysis by Application
5.1 Global Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)
5.2 Global Neuraminidase Inhibitor Revenue Market Share by Application (2017-2022)
5.3 Global Neuraminidase Inhibitor Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GlaxoSmithKline Neuraminidase Inhibitor Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Gilead Sciences Neuraminidase Inhibitor Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 F. Hoffman-La Roche
6.3.1 F. Hoffman-La Roche Corporation Information
6.3.2 F. Hoffman-La Roche Description and Business Overview
6.3.3 F. Hoffman-La Roche Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2017-2022)
6.3.4 F. Hoffman-La Roche Neuraminidase Inhibitor Product Portfolio
6.3.5 F. Hoffman-La Roche Recent Developments/Updates
6.4 BioCryst
6.4.1 BioCryst Corporation Information
6.4.2 BioCryst Description and Business Overview
6.4.3 BioCryst Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2017-2022)
6.4.4 BioCryst Neuraminidase Inhibitor Product Portfolio
6.4.5 BioCryst Recent Developments/Updates
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description and Business Overview
6.5.3 Daiichi Sankyo Neuraminidase Inhibitor Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Daiichi Sankyo Neuraminidase Inhibitor Product Portfolio
6.5.5 Daiichi Sankyo Recent Developments/Updates
7 Neuraminidase Inhibitor Manufacturing Cost Analysis
7.1 Neuraminidase Inhibitor Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neuraminidase Inhibitor
7.4 Neuraminidase Inhibitor Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neuraminidase Inhibitor Distributors List
8.3 Neuraminidase Inhibitor Customers
9 Neuraminidase Inhibitor Market Dynamics
9.1 Neuraminidase Inhibitor Industry Trends
9.2 Neuraminidase Inhibitor Market Drivers
9.3 Neuraminidase Inhibitor Market Challenges
9.4 Neuraminidase Inhibitor Market Restraints
10 Global Market Forecast
10.1 Neuraminidase Inhibitor Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neuraminidase Inhibitor by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Neuraminidase Inhibitor by Type (2023-2028)
10.2 Neuraminidase Inhibitor Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neuraminidase Inhibitor by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Neuraminidase Inhibitor by Application (2023-2028)
10.3 Neuraminidase Inhibitor Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neuraminidase Inhibitor by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Neuraminidase Inhibitor by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Neuraminidase Inhibitor Market Research Report 2022
List of TablesTable 1. Global Neuraminidase Inhibitor Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Neuraminidase Inhibitor Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Neuraminidase Inhibitor Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Neuraminidase Inhibitor Market Competitive Situation by Manufacturers in 2021
Table 5. Global Neuraminidase Inhibitor Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Neuraminidase Inhibitor Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Neuraminidase Inhibitor Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Neuraminidase Inhibitor Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Neuraminidase Inhibitor Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Neuraminidase Inhibitor Manufacturing Sites and Area Served
Table 11. Manufacturers Neuraminidase Inhibitor Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neuraminidase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuraminidase Inhibitor as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neuraminidase Inhibitor Sales by Region (2017-2022) & (K Units)
Table 16. Global Neuraminidase Inhibitor Sales Market Share by Region (2017-2022)
Table 17. Global Neuraminidase Inhibitor Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Neuraminidase Inhibitor Revenue Market Share by Region (2017-2022)
Table 19. North America Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 20. North America Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)
Table 21. North America Neuraminidase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)
Table 23. Europe Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 24. Europe Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)
Table 25. Europe Neuraminidase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Neuraminidase Inhibitor Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Neuraminidase Inhibitor Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Neuraminidase Inhibitor Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Neuraminidase Inhibitor Revenue Market Share by Region (2017-2022)
Table 31. Latin America Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)
Table 33. Latin America Neuraminidase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Neuraminidase Inhibitor Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Neuraminidase Inhibitor Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Neuraminidase Inhibitor Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Neuraminidase Inhibitor Revenue Market Share by Country (2017-2022)
Table 39. Global Neuraminidase Inhibitor Sales by Type (2017-2022) & (K Units)
Table 40. Global Neuraminidase Inhibitor Sales Market Share by Type (2017-2022)
Table 41. Global Neuraminidase Inhibitor Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Neuraminidase Inhibitor Revenue Share by Type (2017-2022)
Table 43. Global Neuraminidase Inhibitor Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Neuraminidase Inhibitor Sales (K Units) by Application (2017-2022)
Table 45. Global Neuraminidase Inhibitor Sales Market Share by Application (2017-2022)
Table 46. Global Neuraminidase Inhibitor Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Neuraminidase Inhibitor Revenue Share by Application (2017-2022)
Table 48. Global Neuraminidase Inhibitor Price by Application (2017-2022) & (US$/Unit)
Table 49. GlaxoSmithKline Corporation Information
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GlaxoSmithKline Neuraminidase Inhibitor Product
Table 53. GlaxoSmithKline Recent Developments/Updates
Table 54. Gilead Sciences Corporation Information
Table 55. Gilead Sciences Description and Business Overview
Table 56. Gilead Sciences Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Gilead Sciences Neuraminidase Inhibitor Product
Table 58. Gilead Sciences Recent Developments/Updates
Table 59. F. Hoffman-La Roche Corporation Information
Table 60. F. Hoffman-La Roche Description and Business Overview
Table 61. F. Hoffman-La Roche Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. F. Hoffman-La Roche Neuraminidase Inhibitor Product
Table 63. F. Hoffman-La Roche Recent Developments/Updates
Table 64. BioCryst Corporation Information
Table 65. BioCryst Description and Business Overview
Table 66. BioCryst Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. BioCryst Neuraminidase Inhibitor Product
Table 68. BioCryst Recent Developments/Updates
Table 69. Daiichi Sankyo Corporation Information
Table 70. Daiichi Sankyo Description and Business Overview
Table 71. Daiichi Sankyo Neuraminidase Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Daiichi Sankyo Neuraminidase Inhibitor Product
Table 73. Daiichi Sankyo Recent Developments/Updates
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Neuraminidase Inhibitor Distributors List
Table 77. Neuraminidase Inhibitor Customers List
Table 78. Neuraminidase Inhibitor Market Trends
Table 79. Neuraminidase Inhibitor Market Drivers
Table 80. Neuraminidase Inhibitor Market Challenges
Table 81. Neuraminidase Inhibitor Market Restraints
Table 82. Global Neuraminidase Inhibitor Sales Forecast by Type (2023-2028) & (K Units)
Table 83. Global Neuraminidase Inhibitor Sales Market Share Forecast by Type (2023-2028)
Table 84. Global Neuraminidase Inhibitor Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 85. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Type (2023-2028)
Table 86. Global Neuraminidase Inhibitor Sales Forecast by Application (2023-2028) & (K Units)
Table 87. Global Neuraminidase Inhibitor Sales Market Share Forecast by Application (2023-2028)
Table 88. Global Neuraminidase Inhibitor Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Application (2023-2028)
Table 90. Global Neuraminidase Inhibitor Sales Forecast by Region (2023-2028) & (K Units)
Table 91. Global Neuraminidase Inhibitor Sales Market Share Forecast by Region (2023-2028)
Table 92. Global Neuraminidase Inhibitor Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 93. Global Neuraminidase Inhibitor Revenue Market Share Forecast by Region (2023-2028)
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuraminidase Inhibitor
Figure 2. Global Neuraminidase Inhibitor Market Share by Type in 2021 & 2028
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Laninamivir Product Picture
Figure 7. Global Neuraminidase Inhibitor Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Retail Stores
Figure 11. Others
Figure 12. Global Neuraminidase Inhibitor Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Neuraminidase Inhibitor Market Size (2017-2028) & (US$ Million)
Figure 14. Global Neuraminidase Inhibitor Sales (2017-2028) & (K Units)
Figure 15. Neuraminidase Inhibitor Sales Share by Manufacturers in 2021
Figure 16. Global Neuraminidase Inhibitor Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Neuraminidase Inhibitor Players: Market Share by Revenue in 2021
Figure 18. Neuraminidase Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Neuraminidase Inhibitor Sales Market Share by Region (2017-2022)
Figure 20. Global Neuraminidase Inhibitor Sales Market Share by Region in 2021
Figure 21. Global Neuraminidase Inhibitor Revenue Market Share by Region (2017-2022)
Figure 22. Global Neuraminidase Inhibitor Revenue Market Share by Region in 2021
Figure 23. United States Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. China Taiwan Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Neuraminidase Inhibitor Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Neuraminidase Inhibitor by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Neuraminidase Inhibitor
Figure 47. Manufacturing Process Analysis of Neuraminidase Inhibitor
Figure 48. Neuraminidase Inhibitor Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Keyplayers in Global Neuraminidase Inhibitor Market Research Report 2022
GlaxoSmithKlineGilead Sciences
F. Hoffman-La Roche
BioCryst
Daiichi Sankyo